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A b s t r a c t  
 
The demand of fast disintegrating tablets has been growing during the last decade, due to the 
characteristics of fast disintegrating sublingual tablets for the potential emergency treatment. In 
terms of permeability, the sublingual area of the oral cavity (i.e, the floor of the mouth) is more 
permeable than the buccal (cheek) area, which in turn is more permeable than the palatal (roof) of 
the mouth. Drug delivery through the oral mucous membrane is considered to be a promising 
alternative to the oral route. Fast disintegrating sublingual tablets may lead to significant 
improvements over current treatment options for specific patient group, for instance pediatric and 
geriatric patients. This review highlights the mechanism of sublingual absorption, factors affecting 
sublingual absorption, formulation techniques, types of sublingual tablets, advantages, evaluation 
parameters and commercially available sublingual dosage forms. 
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Introduction 
Tablet that disintegrates or dissolve rapidly in the patients mouth 
are convenient for young children, elderly patients, mentally 
retarded and bedridden patients who used to suffer most probably 
with the problem of dysphagia and hand tremors. A fast dissolving 
sublingual tablet when placed in the mouth, rapidly get dispersed 
or dissolved and swallowed in the form of liquid. When sublingual 
tablets placed under the tongue, it produces immediate systemic 
effect by enabling the drug absorbed quickly or directly through 
mucosal lining of the mouth beneath the tongue.  The drug 
absorbed from stomach goes to mesenteric circulation which 
connects through portal vein. Thus absorption through oral cavity 
avoid first pass metabolism. The sublingual tablets are usually 
small and flat, compressed lightly to keep them soft. The tablets 
must dissolve quickly allowing the API to be absorbed quickly. ItÊs 
designed to dissolve in small quantity of saliva; after the tablet is 
placed in the mouth below the tongue, the patient should avoid 
eating, drinking, smoking and possibly talking in order to keep the 
tablet in place. Systemic drug delivery through the sublingual 
route had emerged from the desire to provide immediate onset of 
pharmacological action[1-3].Sublingual products have been 
designed for numerous indications ranging from migraine (for 
which rapid onset of action is important) to mental illness(for 
which patient compliance is important for treating chronic 
indications such as depression and schizophrenia) . Sublingual 
route provides [3-10] timeÊs greater absorption of the drug than 
oral route and is only surpassed by hypodermic injection. 
Sublingual route is very much appropriate for short-acting drugs. 
Most of the drugs which are administered through the sublingual 
route are absorbed by simple diffusion; here the sublingual area 
acts like a litmus paper readily soaking up the substances; 
however not all the substances are permeable and accessible to 
oral mucosa. Majority of drugs which are administered through 
sublingual route falls in the category of antianginal drug. Systemic 
drug delivery through the sublingual route had emerged from the 
desire to provide immediate onset of pharmacological effect. 
Sublingual route usually produces a faster onset of action than 
orally ingested tablets and the portion absorbed through the 
sublingual blood vessels bypasses the hepatic first pass 
metabolic processes[4]. Because of underdeveloped muscular 
and nervous system swallowing problems is common in childrens, 
and this could be easily overcome with the help of fast 
disintegrating sublingual tablets. Oral route of drug administration 
has been considered as the most popular one because it holds an 
edge over other routes such as it is the most natural , 
uncomplicated, convenient, safe means to administer drugs, 
greater flexibility in dosage form design , ease of production and 
low cost. By selecting the appropriate pharmaceutical excipients 
in the correct proportion, in combination with optimal 
manufacturing techniques the sublingual tablets could be 
prepared effectively [5]. In past few days oral mucosa including 
ISSN: 0975-0215 
  
This work is licensed under a Creative Commons Attribution 3.0 License.  
Singh et al. International Journal of Drug Delivery 4 (4) 407-417 [2012] 
 
PAGE | 408 |
 
buccal mucosa and sublingual mucosa has received much 
attention compared to conventional oral administration.  
Asenapine sublingual tablets provide improved bioavailability 
which is used for the treatment of schizophrenia and manic/ mixed 
episodes of bipolar disorder. Asenapine when administered 
sublingually its bioavailability comes out to be (35%) but only, 
(<2%) if ingested orally. Asenapine sublingual tablets are 
available in 5mg and10mg strengths which dissolve in saliva 
within approximately (10) seconds [6]. In the same way 
manidipine sublingual tablets could be given to adult and elderly 
patients who are suffering from hypertension [7]. Patients with 
cystic fibrosis in order to improve their quality of life are going for 
lung transplantation and in this case sublingual tacrolimus for 
immunosuppresion in lung transplantation proves to be a best 
alternative in cystic fibrosis.Sublingual tacrolimus a new 
calcineurin inhibitor provides pharmacokinetic advantages such 
as good permeability, rapid absorption, acceptable bioavailability 
and easy accessibility. From an economic point of view sublingual 
route holds an edge over intravenous route [8, 9].  Similarly 
sublingual formulations of Fentanyl allows rapid passage into the 
bloodstream and avoids first pass metabolism and therefore more 
likely to match the time course of break through pain episodes in 
comparison to oral formulations. Sublingual formulations of 
Fentanyl prove to be a valuable formulation for pain management. 
The physicochemical properties of Fentanyl allow the 
development of several formulations [10]. Novel Zolpidem 
formulations such as extended-release form, sublingual 
formulations are becoming the global market leader in the 
hypnotic area. EDULARTM ă a new sublingual formulation of 
Zolpidem that has been developed for the treatment of sleep- 
onset insomnia. Zolpidem proves to be a suitable and well-
tolerated drug, and because of this it is known to be one of the 
most popular drugs [11, 12].  The sublingual formulations are also 
used for acute analgesia in prehospital and in hospital emergency 
department care, and also for pediatric acute pain management 
[13]. Misoprostol is also a suitable drug candidate which could be 
given sublingually for the treatment of PPH (POSTPARTUM 
HAEMORRHAGE), a common cause of excessive bleeding after 
childbirth. PPH remains a major killer of woman worldwide. 
However due to quicker and higher plasma concentration 
sublingual dose of 600 microgram of Misoprostol produces high 
fever and shivering in women. An 800microgram of Misoprostol 
appears to be a good first line treatment for controlling PPH [14-
16]. 
Drugs such as zolmitriptan, ergotamine Tartrate could also be 
given sublingually in the treatment of migraine. Nicotine 
replacement therapy is becoming popular now days in order to 
achieve the goal of smoking cessation. Sublingual preparations of 
nicotine prove to be a good alternative for smoking cessation 
therapy [17].  
Sublingual Glands 
Another name of sublingual gland is salivary glands which are 
present in the floor of the mouth, underneath the tongue. Drugs 
having short delivery and infrequent dosing regimen could be 
delivered successfully through sublingual route because of high 
permeability and rich blood supply, the sublingual route produces 
a rapid onset of action. A good oral hygiene could be promoted 
with the help of sublingual glands. Sublingual glands are also 
known for their binding and lubricating functions, and sublingual 
gland secretion makes the food slippery and easily swallowable. 
High content of saliva in the masticated food helps the food to 
move without any difficulty. 
Saliva secretion plays a major role in shaping the principle 
physiological environment of oral cavity in terms of ph, fluid 
volume and composition. Saliva secretion has been promoted by 
3 major salivary glands which are-parotid, submaxillary, 
sublingual glands. However   minor salivary or buccal   glands are 
also involved in saliva secretions which are situated in or 
immediately below the mucosa. Saliva regulates oral microbial 
flora by maintaining the oral ph and enzyme activity. Sublingual 
glands are known for their viscous saliva with limited enzymatic 
activity whereas parotid and submaxillary gland produces watery 
secretion. Saliva helps in lubricating the oral cavity; it facilitates 
swallowing and prevents demineralization of the teeth.  
Approximately 0.5-2.0L of saliva has been secreted by salivary 
gland. However the volume of saliva which is available constantly 
is around 1.1ml, thus providing a relatively low fluid volume 
available for drug release from delivery systems compared to GI 
tract. If we compare the GI fluid and saliva, saliva is relatively less 
viscous. The flow rate of saliva which in turn depends on 3 
factors-the time of day, the type of stimulus and the degree of 
stimulation. In table1; thickness and surface area of oral cavity 
membranes have been discussed. Figure 1 shows mechanism of 
transportation of drugs through sublingual route into the arterial  
circulation [18].  
 
Figure 1: Mechanism showing sublingual absorption 
of drugs 
 
 
Figure 2: Steps in Direct Compression Technique 
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Drugs For Sublingual Administration 
Sublingual drug administration is applied in the field of 
cardiovascular drugs, steroids, some barbiturates and enzymes. It 
has been a developing field in the administration of many vitamins 
and minerals which are found to be readily and thoroughly 
absorbed by this method. Nutrition which are absorbed 
sublingually avoids exposure to the gastric system and liver, 
means direct nutritional benefits particularly important for sufferers 
of gastrointestinal difficulties such as ulcers, hyperactive gut, 
coeliac disease, those with compromised digestion. Drugs like 
cardiovascular drugs such as nitrites and nitrates, analgesics 
such as morphine, anti-hypertensive such as nifedipine, 
bronchodilators such as fenoterol could be administered 
successfully through sublingual route to show their rapid onset of 
action. Treatment of angina pectoris, hypertension, and 
antiatherosclerotic activity could be done effectively with the 
sublingual dosage form because it offers the fast release of drug 
from the formulation and it reaches the systemic circulation 
directly which bypasses the first pass metabolism of drugs. Fast 
disintegrating sublingual tablets could be used for the potential 
emergency treatment. The demand of fast disintegrating 
sublingual tablets has been increasing day by day because of the 
swallowing difficulties of geriatric and pediatric patients. Because 
of easy administration and better patient compliance, fast 
disintegrating sublingual formulations has become popular as-
ÂNDDSÊ (NOVEL DRUG DELIVERY SYSTEM). Drugs like 
lisinopril could be delivered through sublingual route for the 
treatment of hypertension which is caused by obesity, stress, 
decreased physical activity, increased salt intake, and decreased 
calcium and potassium intake. Through sublingual route as shown 
in figure 3, treatment of cardiovascular disease could be done 
effectively because it offers faster disintegration of tablet, faster 
onset of action, and rapid absorption of drug by sublingual 
mucosa blood vessels. Moreover, drug candidates that undergo 
pregastric absorption when formulated as ODT may show 
increased oral bioavailability. Sublingual route is mostly useful for 
fastest onset of action as in the case of angina pectoris. The 
buccal mucosa lines the inner cheek, and buccal formulations are 
placed in the mouth between the upper gingivae (gums) and 
(cheek) to treat local and systemic conditions. The use of an ODT 
formulation of ondansetron has been found to be helpful in the 
treatment of children as young as 6 months of age suffering from 
gastroenteritis and dehydration [19-21]. 
Advantages Of Sublingual Tablets 
• When sublingual tablets placed under the tongue, it 
produces immediate systemic effect by enabling the 
drug absorbed quickly or directly through mucosal lining 
of the mouth beneath the tongue. 
• Dose gets reduced 
• Onset of action is very fast 
• Improved bioavailability 
• Less side effects 
• Effective in disease like nausea, vomiting, migraine, 
schizophrenia. 
• No need of water for administering tablet 
• Provides sustained drug delivery 
• Ease of drug administration gets increased 
• Sublingual area is much more permeable than buccal 
area.  
• Bypass GI tract and hepatic portal system, therefore it 
increases the bioavailability of orally administered drugs 
that otherwise undergo hepatic first pass metabolism 
[22], [23]. 
 Disadvantages Of Sublingual Tablets 
• Area available for absorption is much less. 
• Unsuitable for bitter drugs 
• Poor  Patient compliance  
• Eating, drinking, and smoking is not allowed. 
• Administration of highly ionic drug is not allowed. 
• Administration of high dose is not possible [24],[25]. 
Mechanism Of Sublingual Absorption 
The absorption potential of oral mucosa is influenced by the lipid 
solubility and therefore the permeability of the solution, ionization 
potential, ph, molecular weight of the substance. Absorption of 
some drugs through oral mucosa is shown to increase when 
carrier ph is increasing (more acidic) and decrease with a 
lowering ph (more alkaline).Cells of oral epithelium and epidermis 
are also capable of absorbing by endocytosis (the uptake of 
particles by a cell as if by wrapping itself around it).These 
engulfed particles are usually too large to diffuse through its wall. 
The oral cavity is highly acceptable by the patients; the mucosa is 
relatively permeable with rich blood supply. It is robust and shows 
short recovery times after stress or damage and the virtual lack of 
langerhans cell makes the mucosa tolerant to potential allergens. 
These factors make the oral mucosal cavity a very attractive and 
feasible site for systemic drug delivery. Besides the biochemical 
characteristics of the buccal and sublingual membrane which are 
responsible for the barrier functions and permeability. Various 
factors of the drug molecule influence the extent of permeation 
through the membrane-Lipid solubility, degree of ionization, pka of 
the drug, ph of the drug solution, presence of saliva, membrane 
characteristics, molecular weight and size of the drug. Various 
physicochemical properties of the formulation and the presence or 
absence of permeation enhancers all affect the absorption and 
permeation of drugs through oral mucosa. However peroral 
administration of drugs has disadvantages such as- hepatic first 
pass metabolism and enzymatic degradation within 
gastrointestinal tract. So there has been a growing interest in the 
delivery of the therapeutic agents through various transmucosal 
routes to provide a therapeutic amount of the drug to the proper 
site in body to promptly achieve and then maintain the desired 
concentration. The sublingual route provides rapid absorption and 
acceptable bioavailability of many drugs and is one of the most 
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convenient, accessible and well accepted route. The sublingual 
mucosa is considered to be more permeable than buccal area 
and it is not able to provide the rapid absorption and good 
bioavailability. The sublingual mucosa is difficult for device 
placement because it lacks an expanse of smooth muscles or 
immobile mucosa and is constantly washed by a considerable 
amount of saliva. Because of high permeability and rich blood 
supply sublingual route provides a rapid onset of action. Moreover 
the absorption of drugs through the highly vascular lining of mouth 
moves the drug through the sublingual or buccal capillaries and 
veins to the jugular veins and superior vena cava directly to the 
heart and arterial circulation, without passing the liver, thus 
avoiding hepatic first pass metabolism. Moreover drugs showing 
poor and erratic absorption from the stomach; or intestine can be 
administered through the oral mucosa [26-28]. 
Types Of Sublingual Tablets 
Fast Disintegrating Sublingual Tablets 
Tablets that disintegrate or dissolve rapidly in the patients mouth 
are convenient for young children, the elderly;(pediatric, 
geriatric)patients with swallowing difficulties and in situations 
where potable liquids are not available.FDT is defined as a solid 
dosage form that contains medicinal substance and disintegrates 
rapidly(within few seconds) without water when kept on tongue. 
The drug is released, dissolved, or dispersed in saliva and then 
swallowed and absorbed across the git. FDT in general offers 
improved convenience and are frequently preferred over 
conventional solid oral dosage forms.ODT may lead to significant 
improvements over current treatment options for specific patient 
group, for instance pediatric patients. The European medicines 
agency committee for medicinal products for human use (CHMP) 
described ODT as having-great promise for children. The potential 
benefits of ODT formulation could be fully realized by considering 
the additional requirements of this group. The size and 
disintegration time play a very important role in commercial 
potential of the formulation. A fast disintegration time reduces any 
choking hazard and will also make it harder to spit out the dose. 
Similarly the taste and texture of pediatric formulation are critical 
to facilitate compliance in children, particularly in chronic 
conditions where repeated administration may be an issue. FDT 
sublingual tablets may show increased oral bioavailability. From 
the perspective of pharmaceutical industry, sublingual tablets may 
provide new business opportunities in the form of product 
differentiation, line extension and life cycle management, 
exclusivity, uniqueness and patent life extension. ODT tablets are 
also called as orodipersible   tablets, quick disintegrating tablets, 
and mouth dissolving tablets, fast disintegrating, fast dissolving, 
porous tablets, rapid dissolving tablets, and rapimelts. Water-
wicking and swelling are the 2 most important mechanisms of 
disintegrant action for most of the sublingual tablets. Table 2 
depicts the excipients used in formulation of sublingual tablets. 
Water- wicking is the ability to draw water into the tablet matrix 
.Both the extent of water uptake and rate of water uptake are 
critically important. Exposure to water can cause ingredients to 
swell and exert pressure against surrounding tablet or capsule 
ingredients causing existing bonds between particles to break. In 
most of the sublingual tablets-sodium starch glycolate has been to 
promote rapid disintegration and dissolution of solid dosage form 
[29, 30].  
Bioadhesive Sublingual Tablets 
The new sublingual tablet concept presented is based on 
interactive mixtures consisting of a    water soluble carrier covered 
with fine drug particles and a bioadhesive component. With this 
approach it is possible to obtain a rapid dissolution in combination 
with bioadhesive retention of the drug in the oral cavity [31]. 
Lipid Matrix Sublingual Tablets 
Lipid matrix sublingual tablets is a bioavailable, quick, convenient 
and consistent dosage forms for many specially nutraceuticals 
that are often taken orally. Lipid matrix sublingual tablets is 
formulated  using advances in sublingual and liposomal 
technology to create a dosage form that offers a faster and more 
complete absorption than traditional oral routes of administration. 
Sublingual Vitamin Tablets                                                              
The only sublingual vitamin that all doctors recommend is vitamin 
B12     (cyanocobalamin).Vitamin-B12 is very much helpful in our 
bodyÊs metabolism. It is recommended to be taken orally. 
Sublingual Immunotherapy 
Sublingual immunotherapy, or SLIT, is a form of immunotherapy 
that involves putting drops of allergen extracts under the tongue. 
SLIT is usually delivered 1 of 2 ways-drops or tablets of allergen 
extracts are placed under the tongue, then either swallowed or 
spat out. Sublingual immunotherapy is very much helpful in the 
case of SAC (seasonal allergic conjunctivitis) and PAC (Perennial 
allergic conjunctivitis) which are spreading at a much faster rate 
among people who are working in industries and it needs longer 
sublingual immunotherapy, often one year around with mast cell 
stabilizers, antihistamines and sometimes local steroids. 
Conjunctivitis additionally needs corticosteroids and if needed 
cyclosporine drops are administered for longer time. WHO 
(WORLD HEALTH ORGANISATION) recommends SIT (allergen 
specific immunotherapy) for the patients with severe allergic 
conjunctivitis or asthma. SIT involves the monthly vaccination 
lasting for 3 years and this therapy may have side effects such as 
anaphylactic reactions. Therefore other administration routes 
have been considered such as sublingual immunotherapy (SLIT) 
with daily administration for at least 3 year is a new promising and 
safe alternative for SIT. Sublingual immunotherapy has an 
advantage over subcutaneous immunotherapy and it is one of the 
most effective and safe treatment for allergic-rhinitis. SLIT has 
gained ample evidence of efficacy and safety and in some 
European countries is currently used more frequently than 
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sublingual immunotherapy (SCIT). Apart from its better safety 
profile , the advantage of SLIT over SCIT are with regard to 
compliance, which is higher because SLIT does not need to be 
administered in a medical setting and is much more cost-effective, 
but the desired outcome exist only if SLIT meets its needs. In 
recent years sublingual immunotherapy has emerged as an actual 
treatment option because of its clinical efficacy and safety. 
Technology Used In Preparation Of Sublingual Tablets 
Among different techniques which could be used for the 
formulation of sublingual tablets are as follows-freeze drying 
technology, spray drying technology, sublimation method, and 
direct compression technology. Direct compression could be 
considered as an ideal method for formulating sublingual tablets 
because of following edges which it holds over other methods- 
• DoesnÊt require water or heat during formulation 
• More economic in comparison to other procedures 
• Fewer manufacturing steps and pieces of equipment 
• Reduces labor costs 
• Less process validation 
• Lower consumption of power 
• Avoidance of high compaction pressure involves in 
producing tablets by slugging or roll compaction 
• Greater stability of tablets on aging 
• Prime particle dissociation. Each primary drug particle is 
liberated from the tablet mass and is available for 
dissolution. Disintegrate rapidly to the primary particle 
size. 
• Elimination of granulation process. 
• No pretreatment of the powder blend is required 
• Elimination of variabilities in wet granulation process 
[32].  
Direct compression is one of these techniques which require 
incorporation of a superdisintegrant into the formulation or use of 
highly water soluble excipients to achieve fast tablet 
disintegration. Direct compression is appropriate for chemicals 
with flowing and cohesive properties. Direct compression is the 
ideal method for heat-labile medications; However the direct 
compression method is very sensitive to the changes in the type 
and proportional of excipients and in the compression forces, 
when used to achieve tablets of suitable hardness without 
compromising the rapid disintegration characteristics; unique 
packaging methods such as strip packaging, could be used to 
compensate for the problem of extreme friability of rapidly 
disintegrating tablets. Bi et al were the first to evaluate the ideal 
excipients proportions and other related parameters using a 
superdisintegrant in order to formulate durable fast disintegrating 
sublingual tablets for oral administration [33],[34]. A combination 
of superdisintegrants i.e, sodium starch glycolate; croscarmellose 
sodium, crospovidone were used along with directly compressible 
mannitol to enhance mouthfeel. In the present date orodipersible 
tablets are designed with a view to enhance patient compliance. 
To improve the compression characteristics of the mixture-Some 
powder are difficult to compress even if adhesive is incorporated 
but granules of same formulation can be much more easily 
compressed. The granulation of toxic material will reduce the 
hazard of generation of toxic dust which may arise when handling 
powders. The materials which are slightly hygroscopic can lead to 
cohesion, hygroscopic. The term direct compression is used to 
define the process by which tablets are compressed directly from 
powder-blends of active ingredient and suitable excipients which 
will flow uniformity in the die cavity and forms a firm compact. 
Direct compression methods are very popular because it reduces 
the number of steps involved and the materials required. The 
choice of superdisintegrants for a tablet for a tablet formulation 
depends largely on the nature of drug being used. Water-soluble 
material tends to dissolve rather than disintegrate if an 
appropriate amount of disintegrant is included in the formulation. 
The correlation between tablet disintegration and dissolution is not 
always observable. Lubricants are the agents that act by reducing 
friction by interposing an intermediate layer between the tablet 
constituents and the die-wall during compression and ejection. 
Lubricants are classified according to their   water-solubility. 
Lubricants are most effective when used at lower concentration 
than water-soluble lubricants.  They tend to retard the drug 
dissolution rate as they decrease the effective drug-solvent 
interfacial area by changing the surface characteristics of the 
tablets. To formulate rapidly disintegrating or dissolving tablets 
direct compression is one of the cheapest and convenient 
techniques. Direct compression is one of the best techniques to 
achieve tablets of suitable hardness without compromising the 
rapid disintegration characteristics, extremely fast tablet 
disintegration would be required to enhance the release of drug 
from tablets for rapid absorption by the sublingual mucosa blood 
vessels [35]. 
Challenges In Direct Compression Technology 
Like any other process, direct compression has its own technical 
issues; among which the most important are- 
• High weight and dose variation of the tablets 
• Low mechanical strength of the tablets 
• Capping and lamination of the tablets 
• Adhesion or sticking of powder material on punch tips 
• High friction during tablet ejection. 
In direct compression properties of powder intended to be formed 
tablets and the design, condition of the press play an important 
role in this technology. It should be ensured that the powder 
possesses adequate physical properties and also that a suitable 
well conditioned tablet press is used in terms of the use of forced-
feed devices; and polished , smooth dies and punches. Important 
technical properties of a powder which must be controlled to 
ensure the success of a tabletting operation are- 
• Homogeneity and segregation tendency 
• Flowability 
• Compressibility 
• Compactability  
• Friction and adhesion properties of the powder [36] 
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Fast Melting Technology 
It is known to be one of the most innovated methods in oral drug 
delivery system, is a rapidly growing area of drug delivery. The 
initial success of the FMT formulation led to the development of 
various technologies. These technologies, however still have 
some limitation also. FROSTA-a new technology used for making 
FMT. The frosta technology utilizes the conventional wet-
granulation process and tablet press for cost-effective production 
in tablets, the frosta tablets are mechanically strong with friability 
of <1% and are stable in accelerated stability conditions, when 
packaged in bottle containers. They are robust enough to be 
packaged in multi-tablet vials. The initial success of the FMT 
formulation led to the development of different technologies; the 
FMT technologies can be classified as follows- 
• Freeze drying 
• Molding/Sublimation 
• Compression 
Whatever technology is used, the important properties of 
successful FMT are instant absorption of water into the core of the 
tablets and then fast disintegration of associated particles into 
separate components. 
FMT technology has certain advantages- 
• Easy handling 
• Low cost of production 
• Easy administration 
• No suffocation risk [37-39].  
Sublimaton 
The basic principle involved in preparing fast dissolving tablets by 
sublimation technique is addition of a volatile salt to the tabletting 
component to obtain a substantially homogeneous mixture and 
volatilizing salt. The removal of volatilizing salt creates pores in 
the tablet, which helps in achieving rapid disintegration when the 
tablet comes in contact with saliva. The tablets were subjected to 
vacuum at 80ÀC for 50 min to eliminate volatile components and 
thus create pores in the tablet; volatile salts such as camphor, 
ammonium bicarbonate, naphthalene, urea etc; were also used as 
sublimable components to prepare porous tablets [40],[ 41]. 
Lyophilization 
It is one of the most common processing methods for removing 
moisture from biopharmaceuticals and it also increases the 
stability, tolerance and shelf-life of these products. It is one of the 
well-established processes within the industry. 
Advantages 
• It improves the stability of pharmaceutical products. 
• Drying takes place at very low temperature therefore 
enzyme action gets inhibited. 
• Final dry product occupies the same volume as the 
original solution. 
• Yield highly soluble products 
• Proteins donÊt get denatured as occur with other drying 
methods. 
Disadvantages 
• It yields a very hygroscopic product. 
• Slow process 
• It requires complicated plant which is very expensive. 
Uses 
• The method is applied only to prepare biological 
products for example- 
• Antibiotics (other than penicillin) 
• Blood products and Vaccines (such as BCG, Yellow 
fever, Smallpox). 
Evaluation Of Sublingual Tablets 
General appearance 
The general appearance of the tablet and overall elegance is very 
much important for consumer-acceptance. Therefore the 
organoleptic properties such as 
Colour 
Taste 
Shape and size should be evaluated properly. 
Hardness 
The hardness of the tablet could be determined using the 
Monsanto hardness tester (cadmach). The tablet is placed 
diagonally between the 2 plungers of the tablet hardness tester; 
and then pressure is applied until the tablet broke down into two 
pieces; and the reading on the scale is noted down [42]. 
Friability 
The friability of the tablet could be determined with the help of 
ÂRoche FibrillatorÊ. Friability is a measure of the mechanical 
strength of the tablet. 10 or 20 preweighed tablets are placed in 
the fibrillator and then it has to be rotated at a speed of 25 rpm for 
4 mins. Finally % wt loss should be calculated. The wt loss should 
not be more than 1% [43]. 
 
% FRIABILITY=Loss in wt/Initial wtï100 
Uniformity of weight 
It could be determined with the help of ÂDigital weighing balanceÊ. 
The weight of one tablet    could be determined from the collective 
weight of all tablets. The individual tablets are weighed on a digital 
weighing balance and then it has to be compared with the 
average           weight. In table 3 IP limits for weight variation is 
shown [44]. 
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Table 1: USFDA Specification for drugs taken sublingually 
DRUG HALF-
LIFE 
VOL OF DISTRIBUTION(l|kg) BIOAVAILABILITY
(%) 
TMAX REFERENCE
NITROGLYCERINE 1.5-
7.5mins 
        3.3 40 6.4 USFDA
ASENAPINE     -       20-25 35 1 hr USFDA
SUBOXONE     -         4.9 87  - USFDA
CLOZAPINE 1.2hrs           - - 40 USFDA
ARIPIPRAZOLE 2.3hrs          - - 1hr USFDA
 
 
Table 2: Thickness And Surface Area Of Oral Cavity Membranes 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3: Excipients Used In Sublingual Tablets 
HPMC Tablet binder, Stabilizing agent. 
MCC(Micro Crystalline Cellulose) Diluents, Adsorbent
Lactose Monohydrate Diluent, Tablet binder
Crosspovidone Superdisintegrant
Cross carmellose sodium  Superdisintegrant
Sodium starch glycolate Superdisintegrant
 
 
 
 
 
 
 
ORAL CAVITY MEMBRANE THICKNESS SURFACE AREA 
Buccal  mucosa 500-600 5.2 
Sublingual mucosa 100-200 26.5 
Gingival mucosa 200 - 
Palatal 250 20.1 
Singh et al. International Journal of Drug Delivery 4 (4) 407-417 [2012] 
 
PAGE | 414 |
 
Table 4: Various Processes For Preparing Sublingual Tablets 
NAME OF THE PROCESS ADVANTAGES DISADVANTAGES       USES 
LYOPHILIZATION Well-established 
technique. 
 
Yields highly soluble 
product. 
 
Drying takes place at 
very low temp. 
 
Yields stable and porous 
product. 
Expensive
 
 
Yields a very hygroscopic 
product. 
Slow process 
Used to prepare-
Antibiotics. 
 
Vaccines 
 
Enzyme Preparations 
 
Microbiological cultures. 
 
SPRAY-DRYING 
 
 
 
 
 
 
 
Evaporation is very 
rapid. 
 
 
 
Provides a very large 
surface area. 
 
 
Labor-cost is low. 
 
Product has a high bulk-
density. 
 
The product has a 
uniform particle- size. 
Large space is required for 
installation of equipments. 
 
The thermal-efficiency of the 
drying chamber is rather 
low. 
Used for drying of almost any 
substance in solution or in 
suspension form for ex 
Borax, Citric acid 
Hexamine, Gelatin 
Acacia. 
MASS-EXTRUSION Simple-design.
 
High-efficiency. 
 
Fast-processing ability. 
     NA           NA 
 
 
Table 5: Ip Limits For Weight Variation 
AVERAGE WT OF TABLETS %VARIATION ALLOWED 
80 mg or less            10
60 mg but< 250 mg            7-5
250 mg or more             5
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Table 6: Patents Of Sublingual Medications 
PATENT NO TITLE INVENTOR ASSIGNEE US CLASSIFICATION
US3428728 Timed release sublingual 
medications 
Paul Meredith 
Terrill 
Eli Lilly and 
Company 
              514|509 
US3873727 Stabilization of molded 
sublingual nitroglycerin tablets 
Paul Meredith 
Terrill 
Eli Lilly and 
Company 
             514|509 
 
 
 
Table 7: Marketed Products Of Sublingual Tablet 
BRAND NAME CATEGORY STRENGTH
 
Abstral Fentanyl Citrate 
 
Opioid analgesic 50,100,200,300,400,600,80
0mg 
 
Subulex Buprenorphine 
 
Opioid analgesic 2 ,8 mg 
 
Avitan Lorazepam 
 
Antianxiety 1,2 mg 
 
Edular Zolpidem Tartrate 
 
Sedatives/Hypnotics 5, 10 mg 
 
Isordil  Isosorbide Dinitrate 
 
Vasodilators 2,5 mg 
 
Suboxone Buprenorphine  
 
Narcotic+Opioid antagonists 8/2, 0.5 mg 
 
Nitrostat Nitroglycerine 
 
Antianginal 0.3,0.4,0.6 mg 
 
Thickness 
It could be measured with the help of ÂVernier CallipersÊ or 
ÂMicrometerÊ. Thickness should be controlled within 50% variation 
of a standard value [45]. 
Wetting Time 
In this test a circular tissue paper is placed in a petridish and 
tablet is placed on the paper. A certain volume of distilled water is 
added and the time required to cover the entire tablet surface is 
recorded as the wetting time [46]. 
Water Absorption Ratio 
It can be calculated with the help of following equation- 
 
Water absorption ratio= (wlast-wfirst)/w first. 
 
Where, wfirst stands for dry sublingual tablet and wlast for entirely 
wet sublingual tablet [46]. 
Disintegration Test 
The disintegration time could be measured with the help of 
Disintegration test apparatus. One tablet has to be placed in tube 
of the basket; the basket with the bottom surface made of a 
stainless steel screen(mesh no;10) and then it has to be 
immersed in water-bath at 37μ2ÀC.The time required for complete 
disintegration could be determined with the help of stopwatch. 
According to the pharmacopoeial standards; dispersible tablets 
must disintegrate within 3 mins. 
Dissolution Studies 
It could be determined using ÂUSP DISSOLUTION APPARATUSÊ 
(PADDLE TYPE). The dissolution test could be performed using 
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900 ml of ph 6.8 phosphate buffer  at 50-100 rpm , the 
temperature should be maintained at 37μ0.5ÀC .A sample(5 ml) of 
the solution should be withdrawn from the dissolution apparatus 
for every 2 mins; the sample can be replaced with the fresh 
dissolution medium. Then one has to filter the sample with the 
help of whatman filter paper no. Absorbance of these solutions 
could be measured using u.v.spectrophotometer at 290-321 nm. 
In-vitro disintegration time 
By using USP tablet disintegration apparatus with phosphate 
buffer of ph 6.8 as medium, the disintegration time for sublingual 
tablets could be determined.900 ml of phosphate buffer is taken 
as the dissolution medium at 100rpm and at temperature 
37ÀCμ2ÀC.The time in seconds taken for complete disintegration 
of the measured .[46].  
Future Prospects 
Sublingual tablets are one of the most suitable candidates for the 
oral delivery of drugs such as proteins and peptides that have 
limited bioavailability when administered by conventional tablet. 
Injections generally are not favored for use by patients unless 
facilitated by sophisticated auto-injectors. The developments of 
enhanced oral protein delivery technologies by ODTS which may 
release these drugs in the oral cavity are very promising for the 
delivery of high molecular weight proteins and peptides. 
Conclusion 
Due to the ease of access and avoidance of the hepatic 
metabolism, sublingual route offers a promising alternative to 
overcome the limitations of conventional oral drug delivery and 
parenteral administration. Sublingual products were developed to 
overcome the difficulty in swallowing conventional tablets, among 
pediatric, geriatric patients with dysphagia. The target population 
has expanded to those who want convenient dosing without 
water, anywhere anytime. Peak blood levels of most of the 
products administered sublingually are achieved within 10-15 
minutes; which is generally much faster than when those same 
drugs are ingested orally. Sublingual route offers efficient 
absorption as well as quick onset of action. Various types of 
commercially available sublingual dosage forms have been 
discussed in Table 4. 
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